TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18704871

Group type: EXPERIMENTAL
Intervention: Patient education programme provided by a specifically trained psychologist, including individualized units and group lectures.
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Patient education programme measured ten days after CABG surgery.
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group receiving usual care, n=70.
Number of subjects: 140
Study: 15685250

Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 1336

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1336
Study: 14593034

Group type: EXPERIMENTAL
Intervention: Non-commercial funding support for randomised controlled trials
Number of subjects: 1464

Group type: EXPERIMENTAL
Intervention: Drug trials
Number of subjects: 1464

Group type: EXPERIMENTAL
Intervention: NHS research and development programme
Number of subjects: 1464

Group type: EXPERIMENTAL
Intervention: Medical Research Council and medical research charities
Number of subjects: 1464
Study: 10487503

Group type: EXPERIMENTAL
Intervention: Troglitazone (400 mg daily for 12 weeks)
Number of subjects: 12
Study: 9097708

Group type: EXPERIMENTAL
Intervention: PCNA expression in CIN patients
Number of subjects: 156
Study: 1924776

Group type: EXPERIMENTAL
Intervention: Puncture-site-down positioning (n = 36)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Puncture-site-up positioning (n = 19)
Number of subjects: 55
Study: 30236238

Group type: EXPERIMENTAL
Intervention: sugammadex 4 mg kg‐1
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: sugammadex 16 mg kg‐1
Number of subjects: 448

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 448
Study: 27786344

Group type: EXPERIMENTAL
Intervention: Tailored Physical Activity (TPA)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Chronic Pain Self-Management Program (CPSMP)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Reference group
Number of subjects: 141
Study: 24874474

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (RT) with high AEG-1 expression
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Downregulation of AEG-1 in colon cancer cell lines
Number of subjects: 158

Group type: COMPARATOR
Intervention: Normal mucosa
Number of subjects: 158
Study: 21769733

Group type: EXPERIMENTAL
Intervention: 0-10 Numeric Rating Scale (NRS)
Number of subjects: 33
Study: 21266736

Group type: EXPERIMENTAL
Intervention: Live High:Train Low (LHTL, n = 6)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (n = 6)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Nocebo (n = 5)
Number of subjects: 17
Study: 18725113

Group type: EXPERIMENTAL
Intervention: Hypofractionated whole-breast irradiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypofractionated partial-breast irradiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional whole-breast irradiation
Number of subjects: 0
Study: 16624882

Group type: COMPARATOR
Intervention: Dexamethasone 0.15 mg/kg
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Prednisolone 1 mg/kg
Number of subjects: 133
Study: 12728539

Group type: EXPERIMENTAL
Intervention: troglitazone 200 mg/day
Number of subjects: 137

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 137
Study: 10884075

Group type: EXPERIMENTAL
Intervention: Endoscopic carpal tunnel release
Number of subjects: 36

Group type: COMPARATOR
Intervention: Short-incision open carpal tunnel release
Number of subjects: 36
Study: 8741948

Group type: EXPERIMENTAL
Intervention: Alcohol pretreatment (0.5 g/kg and 1.0 g/kg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (no alcohol)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Monetary reinforcement (varying amounts of money)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Visual-analog ratings (good effects)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cardiac output across all alcohol and monetary conditions
Number of subjects: 11
Study: 1414040

Group type: EXPERIMENTAL
Intervention: 15 mg methotrexate (MTX) administered intramuscularly once a week
Number of subjects: 102

Group type: COMPARATOR
Intervention: 50 mg gold sodium thiomalate (GST) administered intramuscularly once a week
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: 15 mg methotrexate (MTX)
Number of subjects: 102

Group type: COMPARATOR
Intervention: 50 mg gold sodium thiomalate (GST)
Number of subjects: 102
Study: 2580179

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg + hydrochlorothiazide (HCTZ) 25 mg twice a day
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Captopril 50 mg + hydrochlorothiazide (HCTZ) 25 mg
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: High-dose captopril (3 X 50-3 X 150 mg, mean = 325 +/- 87 mg/day) changed to low-dose captopril (2 X 50 mg, mean = 96 +/- 14 mg/day) in a fixed combination with 25 mg HCTZ
Number of subjects: 55
Study: 30569654

Group type: EXPERIMENTAL
Intervention: Happy incidental state priming
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fearful incidental state priming
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neutral incidental state priming
Number of subjects: 0
Study: 29726361

Group type: EXPERIMENTAL
Intervention: 0.1% mometasone furoate (MF) cream applied twice daily from day 1 of PMRT to 14 days after PMRT
Number of subjects: 124

Group type: COMPARATOR
Intervention: Eucerin Original (E) cream applied twice daily from day 1 of PMRT to 14 days after PMRT
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 0.1% mometasone furoate (MF) cream
Number of subjects: 124

Group type: COMPARATOR
Intervention: Eucerin Original (E) cream
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 124
Study: 26777097

Group type: EXPERIMENTAL
Intervention: Coronectomy with guided bony regeneration
Number of subjects: 6

Group type: COMPARATOR
Intervention: Coronectomy alone (Control)
Number of subjects: 6
Study: 24932565

Group type: EXPERIMENTAL
Intervention: Marriage Checkup (MC) treatment
Number of subjects: 215

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 215
Study: 22360430

Group type: EXPERIMENTAL
Intervention: 20% glucose solution
Number of subjects: 2

Group type: COMPARATOR
Intervention: Amino acids mixture (F-group)
Number of subjects: 2
Study: 19941285

Group type: EXPERIMENTAL
Intervention: Telephone counseling program (16 sessions over one year)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Resource directory for breast cancer (control group)
Number of subjects: 304
Study: 17641484

Group type: EXPERIMENTAL
Intervention: Computer-aided pathfinding assistance
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standard clinical practice
Number of subjects: 87
Study: 16092310

Group type: EXPERIMENTAL
Intervention: Atropine 0.01mg/kg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Glycopyrrolate 0.005mg/kg
Number of subjects: 90
Study: 12142117

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10453872

Group type: EXPERIMENTAL
Intervention: Oral prednisolone for 3 months (20 mg/d for 8 weeks, 15 mg/d for 2 weeks, and 10 mg/d for 2 weeks) followed by inhaled budesonide (800 microg bid for 15 months)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Placebo tablets followed by placebo inhaler therapy
Number of subjects: 189
Study: 7565828

Group type: EXPERIMENTAL
Intervention: Botulinum toxin-A
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2334037

Group type: EXPERIMENTAL
Intervention: 16 ml/kg of Ringer's acetate solution immediately before spinal anaesthesia (Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 8 ml/kg of Ringer's acetate solution immediately before spinal anaesthesia (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No volume preload (Group C)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Temperature sensation blocked to T7 and above (n = 25)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Block height above T7
Number of subjects: 60
Study: 498720

Group type: EXPERIMENTAL
Intervention: Smoking MH containing 7.5 mg (‐) delta‐9‐tetrahydrocannabinol
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo marihuana (PL)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (not smoking)
Number of subjects: 6
Study: 31828315

Group type: EXPERIMENTAL
Intervention: Complete substitution of cigarettes with e‐cigarettes (CS‐E)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Complete substitution of cigarettes with nicotine gum or lozenge (CS‐NRT)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Ad libitum use of e‐cigarettes (AD‐E)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Continue smoking of usual brand cigarettes (UB)
Number of subjects: 264
Study: 31550872

Group type: EXPERIMENTAL
Intervention: Propofol and ketamine (Group K)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Propofol and remifentanil (Group R)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Evaluation of test conditions (Group K)
Number of subjects: 90
Study: 28480522

Group type: EXPERIMENTAL
Intervention: Velcro ties
Number of subjects: 63

Group type: COMPARATOR
Intervention: Twill ties
Number of subjects: 63
Study: 26202655

Group type: EXPERIMENTAL
Intervention: TIMI classification
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: GUSTO classification
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: PLATO classification
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: BARC classification
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Overall bleeding complications
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Correlation with hemodynamic status
Number of subjects: 106
Study: 24121064

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 22197958

Group type: EXPERIMENTAL
Intervention: Red-visor cap
Number of subjects: 11

Group type: COMPARATOR
Intervention: Nonvisor cap
Number of subjects: 11
Study: 19497944

Group type: EXPERIMENTAL
Intervention: Intensive home visiting (n=67)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Standard services (n=64)
Number of subjects: 131
Study: 16129623

Group type: EXPERIMENTAL
Intervention: Athletes with a history of low-back injury (HxLBI)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Athletes without a history of low-back injury (No HxLBI)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Individuals with first-time injury
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Athletes with single and multiple episode low-back injury
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Athletes with short and long symptom duration
Number of subjects: 242
Study: 12860492

Group type: EXPERIMENTAL
Intervention: Fast-disintegrating oral risperidone tablet (0.5 mg)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional oral risperidone tablet (0.5 mg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Both treatments (fast-disintegrating and conventional)
Number of subjects: 37
Study: 10530501

Group type: EXPERIMENTAL
Intervention: Bio‐Quinone Q10 (100 mg) with Bio‐Antox (n = 13, group 2)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Bio‐Antox (n = 11, group 1)
Number of subjects: 24
Study: 8656146

Group type: EXPERIMENTAL
Intervention: Methimazole 10 mg every 12th h
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Propylthiouracil 100 mg every 12th h
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Methimazole 10 mg every 8th h
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Propylthiouracil 100 mg every 8th h
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Methimazole 10 mg every 6th h
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Propylthiouracil 100 mg every 6th h
Number of subjects: 94
Study: 2068543

Group type: EXPERIMENTAL
Intervention: Homeopathy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 6509781

Group type: EXPERIMENTAL
Intervention: Low doses of T3 therapy (20 micrograms twice a day)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 30902696

Group type: EXPERIMENTAL
Intervention: P‐US‐PCNL
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: S‐US‐PCNL
Number of subjects: 392

Group type: COMPARATOR
Intervention: C‐PCNL
Number of subjects: 392
Study: 30286714

Group type: EXPERIMENTAL
Intervention: Social Fitness Programme
Number of subjects: 17
Study: 26783736

Group type: EXPERIMENTAL
Intervention: MI-based home telehealth program
Number of subjects: 178

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 178
Study: 25179973

Group type: EXPERIMENTAL
Intervention: CABG + mitral valve repair
Number of subjects: 84

Group type: COMPARATOR
Intervention: CABG alone
Number of subjects: 84
Study: 22279559

Group type: EXPERIMENTAL
Intervention: Finger Tapping Test in Virtual Reality (FT(VR))
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Finger Tapping Test in Real World (FT(REAL))
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Intra-class correlation coefficients (ICC) for FT(VR)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Comparison of FT(VR) vs FT(REAL)
Number of subjects: 3
Study: 20807892

Group type: EXPERIMENTAL
Intervention: Once-weekly bortezomib
Number of subjects: 511

Group type: COMPARATOR
Intervention: Twice-weekly bortezomib
Number of subjects: 511
Study: 17674763

Group type: EXPERIMENTAL
Intervention: Mizolastine
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Cetirizine
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 16342083

Group type: EXPERIMENTAL
Intervention: Isokinetic exercises
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Isokinetic exercise and pulse ultrasound for periarticular soft tissue pain
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Isokinetic exercise, pulse ultrasound, and intraarticular hyaluronan therapy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (group IV)
Number of subjects: 140
Study: 12476504

Group type: EXPERIMENTAL
Intervention: Short-stretch compression bandaging
Number of subjects: 65
Study: 10400483

Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Aspirin intolerance
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Anaphylactoid reactions induced by NSAIDs
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Pyrazolones
Number of subjects: 256
Study: 7759787

Group type: EXPERIMENTAL
Intervention: Clonidine (0.04 mg/m2 body surface twice daily for 12 months)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Clonidine withdrawal (P2)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Clonidine reinstatement (P3)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Clonidine (P1)
Number of subjects: 12
Study: 2676257

Group type: EXPERIMENTAL
Intervention: Antihypertensive drug treatment
Number of subjects: 420000

Group type: COMPARATOR
Intervention: Prolonged difference in usual DBP of approximately 6 mmHg
Number of subjects: 420000
Study: 321182

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine dental gel
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo quinine sulfate-containing gel
Number of subjects: 117
Study: 26951059

Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training
Number of subjects: 98

Group type: COMPARATOR
Intervention: Paying Attention in Class
Number of subjects: 98
Study: 30203005

Group type: EXPERIMENTAL
Intervention: Vedolizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Corticosteroid tapering
Number of subjects: 0
Study: 27068999

Group type: EXPERIMENTAL
Intervention: Feedback reports provided through a web-based application with performance scores and benchmark comparisons.
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Performance being benchmarked as low and intermediate.
Number of subjects: 41
Study: 25770117

Group type: EXPERIMENTAL
Intervention: pCMV-vegf165 intramuscular injections (1.2 mg, 2 injections, 14 days apart) with standard pharmacological treatment
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: pCMV-vegf165 intramuscular injections
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard treatment only
Number of subjects: 100
Study: 24187867

Group type: EXPERIMENTAL
Intervention: Yang‐warming and kidney essence‐replenishing herbal paste
Number of subjects: 151

Group type: COMPARATOR
Intervention: Basic treatment according to the Global Initiative for Asthma scheme
Number of subjects: 151
Study: 21217436

Group type: EXPERIMENTAL
Intervention: Cervical intervertebral fusion cage (CIFC)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Cloward procedure (CP)
Number of subjects: 73
Study: 18377900

Group type: EXPERIMENTAL
Intervention: Insemination media with higher nitric oxide metabolite levels
Number of subjects: 11

Group type: COMPARATOR
Intervention: Morphological predictors
Number of subjects: 11
Study: 17576863

Group type: EXPERIMENTAL
Intervention: Pulse steroids in addition to standard intravenous immunoglobulin
Number of subjects: 190
Study: 15547572

Group type: EXPERIMENTAL
Intervention: Comprehensive sexually transmitted disease curriculum (2-hour laboratory module, lectures, syllabus, pretest/posttest)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Attending sexually transmitted disease clinic (n = 47)
Number of subjects: 108

Group type: COMPARATOR
Intervention: No sexually transmitted disease clinic (n = 61)
Number of subjects: 108
Study: 11267855

Group type: EXPERIMENTAL
Intervention: Women informed about normal or benign results at the recall clinic
Number of subjects: 509

Group type: COMPARATOR
Intervention: Women referred to surgical biopsy
Number of subjects: 509
Study: 9384010

Group type: EXPERIMENTAL
Intervention: Accelerated professional development participants
Number of subjects: 41

Group type: COMPARATOR
Intervention: Peer consultation participants
Number of subjects: 41
Study: 8174140

Group type: EXPERIMENTAL
Intervention: Confirmed AMI
Number of subjects: 3

Group type: COMPARATOR
Intervention: Possible AMI
Number of subjects: 3

Group type: COMPARATOR
Intervention: Definitely ruled out AMI
Number of subjects: 3
Study: 2607058

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 5 mg, 10 mg, 15 mg, and 20 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 1110481

Group type: EXPERIMENTAL
Intervention: 5 per cent dextrose in normal saline infusions
Number of subjects: 400

Group type: COMPARATOR
Intervention: 5 per cent dextrose in water
Number of subjects: 400
Study: 31015560

Group type: EXPERIMENTAL
Intervention: Placebo group (verbal suggestion that treatment was effective)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (told that treatment was inert)
Number of subjects: 30
Study: 27896858

Group type: EXPERIMENTAL
Intervention: simeprevir + sofosbuvir + ribavirin (12 weeks)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: simeprevir + sofosbuvir (12 weeks)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: simeprevir + sofosbuvir (24 weeks)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: simeprevir + sofosbuvir (with or without ribavirin)
Number of subjects: 46
Study: 26397029

Group type: EXPERIMENTAL
Intervention: Transurethral vaporesction with a 2 μm CW thulium laser (LVRBT)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Standard transurethral resection with a bipolar electrocautery system (TURBT)
Number of subjects: 292
Study: 23590978

Group type: EXPERIMENTAL
Intervention: Active TBR neurofeedback (NF)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Sham neurofeedback (NF)
Number of subjects: 180
Study: 21750358

Group type: EXPERIMENTAL
Intervention: HiToP (High Tone Power Therapy)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Mock HiToP (placebo)
Number of subjects: 68
Study: 18853250

Group type: EXPERIMENTAL
Intervention: Calcium plus vitamin D supplementation (500 mg of elemental calcium as calcium carbonate plus 200 IU of vitamin D(3) twice daily)
Number of subjects: 36282

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36282

Group type: EXPERIMENTAL
Intervention: Calcium plus vitamin D supplementation
Number of subjects: 36282

Group type: EXPERIMENTAL
Intervention: Calcium plus vitamin D supplementation (1,000 mg of elemental calcium as calcium carbonate plus 400 IU of vitamin D(3) daily)
Number of subjects: 36282
Study: 23285154

Group type: EXPERIMENTAL
Intervention: 100 mg oral doxycycline twice a day for 30 days
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 16019766

Group type: EXPERIMENTAL
Intervention: EMLA cream (local surface anesthesia)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1% prilocaine (periprosthetic nerve blockade)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1% lidocaine (periprosthetic nerve blockade)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo cream (control)
Number of subjects: 80
Study: 12718836

Group type: EXPERIMENTAL
Intervention: GSK MMR vaccine (three lots), 125 subjects each lot
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: GSK MMR vaccine
Number of subjects: 500

Group type: COMPARATOR
Intervention: Merck MMR vaccine, 125 subjects
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: GSK MMR vaccine and Merck MMR vaccine
Number of subjects: 500
Study: 9449500

Group type: EXPERIMENTAL
Intervention: Active challenge with a single-dose drink equivalent to 300 ml of cow's milk
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo challenge
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Active treatment (cow's milk)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both active and placebo treatments
Number of subjects: 20
Study: 8595072

Group type: EXPERIMENTAL
Intervention: Percutaneous ibuprofen gel (500 mg, 10 g 5% gel on the back, area of 20 x 20 cm) with occlusion for 2 h
Number of subjects: 18

Group type: COMPARATOR
Intervention: Oral ibuprofen tablet (400 mg)
Number of subjects: 18
Study: 2226879

Group type: EXPERIMENTAL
Intervention: Acute thrombectomy combined with a temporary arterio‐venous fistula (AVF) and anti‐coagulation
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional anticoagulation
Number of subjects: 41
Study: 389050

Group type: EXPERIMENTAL
Intervention: LRH (Luteinizing Hormone-Releasing Hormone)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13